Target intelligence / Profile preview

DNA helicase B (HELB)

Target
HELB
Molecular classification
Enzyme, DNA helicase, Superfamily 1 helicase (Pif1/RecD2 family)
01

Overview

DNA helicase B (HELB) is a conserved DNA-dependent ATPase and 5′–3′ DNA helicase in higher eukaryotes, particularly humans, where it plays essential roles in the initiation of DNA replication and the cellular responses to replication stress and DNA damage. HELB localizes to the nucleus in the G1 phase to participate in assembly of the replication pre-initiation complex via interactions with DNA polymerase α-primase, CDC45, and TOPBP1. Upon CDK2-mediated phosphorylation at the G1-S transition, HELB is exported to the cytosol but can relocalize to chromatin in response to replication stress or DNA damage. HELB contributes to genomic stability by promoting replication origin firing, stimulating RNA primer synthesis, and regulating homologous recombination through inhibition of long-range resection at DNA double-strand breaks. Dysregulation of HELB has been observed in some cancers, suggesting a role in tumorigenesis. Mutations in HELB or altered expression can compromise DNA replication and DNA repair fidelity, making it a potential biomarker for replication stress and therapeutic target in cancer biology[1][4][7][6].

Other names
DNA helicase BHELBhDHBDHBhelicase (DNA) B
02

Biological functions

DNA replication initiationDNA repair (especially double-strand break repair)Homologous recombination regulationCell cycle progression control (G1 to S phase transition)Genomic stability maintenance
03

Disease associations

Cancer (genomic instability; rare gene fusions involving HELB in tumors)Other genomic instability syndromes (potentially implied by core function)
04

Safety considerations

Loss of HELB function may cause defective DNA replication and increased genomic instabilityDysregulation (including gene fusions) may contribute to oncogenesis

Beyond the preview

Go deeper on DNA helicase B (HELB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA helicase B (HELB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call